“I envy the man who has yet been to Africa, for he has much to see” – Richard Mullin
MMH & Partners Africa (MMH) was established in 2023 to address rising concerns regarding the risks affecting Africa’s health security and medicine supply, due to its dependency on foreign imports from the Global North.
The MMH team has since been capacitated to assist in the facilitation and establishment of a new public health order for Africa, one in which the equitable access to healthcare products is never compromised by global supply or local demand.
Our panel of highly-skilled experts have over 60 years of combined experience in Africa’s healthcare sector and pharmaceutical manufacturing industries, offering private companies and donor funders with access to a number of opportunities geared to unlock growth in Africa’s public and private health sectors.
We have spent a number of years successfully managing large-scale investments into pharmaceutical manufacturing sites, and can assist with all associated aspects of project management, including the physical construction of new production facilities for diagnostics, pharmaceuticals and biologics across Africa.
MMH & Partners Africa regularly communicates on its industry insights, offering key stakeholders, government officials and citizens across the African continent with access to the latest developments and challenges affecting Africa’s medicine supply and health security. The latest news and groundbreaking industry insights from our highly-qualified team of experts can be accessed at your convenience, using the links provided below.
Development of Africa’s Pharmaceutical Manufacturing Framework Critical in HIV Battle
How Can We Build on Mandela’s Healthcare Legacy?
World Local Production Forum 2023: Industry Experts Discuss Regulatory Challenges Affecting Equitable Access to Medicine & Healthcare Products in Africa
Experts Emphasize Urgent Need for Intellectual Property Rights to Boost Medicine Security in Africa
Mynhardt Discusses Importance of the Unrenewed PEPFAR
For access to our strategic recommendations for the development of Southern Africa’s pharmaceutical manufacturing framework, as prepared at the request of H.E. President Cyril Ramaphosa for the Presidency of the Republic of South Africa, please see below. This section includes our Medical Journal Articles and policy position papers as drafted in collaboration with industry experts.
Report Submitted to the Presidency of the Republic of SA: Pharmaceutical Manufacturing & Industry Capacity Building in South Africa
This position paper offers the Presidency of the Republic of South Africa and the National Department of Health (DOH) with invaluable industry insights by MMH & Partners, Africa (Pty) Ltd, towards achieving a new public health order for Africa based on six strategic objectives.
MMH Press Statement Nov. 2023: World Local Production Forum 2023, Industry Experts Confirm Regulatory Challenges Affecting Equitable Access to Medicine & Healthcare Products in Africa
Citing conditions affecting the development of Africa’s new public health order, industry experts in The Hague agreed that a global regulatory standard would remain a critical undertaking to decrease Africa’s reliance on foreign healthcare products and imports.
MMH Press Statement Oct. 2023: US Congress Failure to Authorize Renewal of PEPFAR Emphasizes Critical Need to Prioritize Expansion of Pharmaceutical Manufacturing in South Africa
Reports have confirmed that the United States Congress has failed to reauthorise a five-year budget for the world’s largest aid programme for global health, by its 30 September deadline in 2023.
Journal of Public Health in Africa; Volume 14 No 8: The Expansion of Pharmaceutical Manufacturing Industries Critical to Strengthen African Health Systems & Decrease Reliance on Foreign Imports
In Africa, 99% of all vaccines administered to people are imported. The consequences of this are notably concerning – and became painfully evident after COVID-19.
Editorial for the JPHIA: Pharmaceutical Manufacturing Plan for Africa Critical for Pandemic Preparedness, Prevention & Response
WHO’s scientific research and findings must incentivise public and private stakeholders to work together to spearhead the development of Africa’s pharmaceutical and biological manufacturing framework if we want to improve our ability to prevent, detect and limit the transmission of HIV.
Journal of Public Health in Africa; Volume 14 No 10: Empowering Africa’s Healthcare Future: The Crucial Role of Human Capital Development in Bio- & Pharmaceutical Manufacturing
Africa, a continent of immense potential, has long grappled with complex healthcare challenges. The COVID -19 pandemic has accentuated the urgency of fortifying the continent’s healthcare infrastructure. At the heart of this transformation lies the imperative of human capital development in bio & pharma-manufacturing.